Tirzepatide

October 21, 2026 · 2 min read

Tirzepatide: a research overview of the GIP and GLP-1 dual agonist

How tirzepatide acts on two incretin receptors, and what the SURMOUNT-1 phase 3 trial and later reviews report about it.

Tirzepatide · Metabolic research